<DOC>
	<DOCNO>NCT00235950</DOCNO>
	<brief_summary>The purpose study compare efficacy two lipid lower treatment , rosuvastatin ( 10-40 mg ) atorvastatin ( 20-80 mg ) reduce low-density lipoprotein cholesterol ( LDL-C ) level 16 week treatment patient coronary heart disease</brief_summary>
	<brief_title>Assessment Lipid Lowering Effect Rosuvastatin Compared Atorvastatin Subjects With Coronary Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>18 year old , establish coronary heart disease previously perform PCI , previous treatment clopidogrel , ongoing statin treatment , LDLC &gt; 2.9 mmol/L , sign informed consent . Ongoing treatment clopidogrel 12 week randomisation , hypersensitivity study drug , active liver disease , moderate severe renal impairment , hereditary know muscular neuromuscular disease and/or increase serum CK , pregnancy lactation childbearing potential practising adequate method contraception , use concomitant medication possible interaction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Percutaeous Coronary Intervention ( PCI )</keyword>
</DOC>